Blulux Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 20 Year, 11 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 8.30 M
- Revenue Growth -11.45%
- Profit Growth -38.53%
- Ebitda -174.98%
- Net Worth 4.10%
- Total Assets 15.85%
About Blulux Laboratories
Blulux Laboratories Private Limited (BLPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 March 2004 and has a history of 20 years and 11 months. Its registered office is in Delhi, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹8.30 M.
Ajay Bhatia, Jogesh Bhatia, and Sant Bhatia serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24119DL2004PTC125154
- Company No.
125154
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Mar 2004
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Blulux Laboratories Private Limited offer?
Blulux Laboratories Private Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Chemical Test Kits, Medical Laboratory Instruments, Clinical Reagents, Laboratory Reagents, Biocides, Microbial Culture, PH Meter, pH Indicators, Natural Dyes.
Who are the key members and board of directors at Blulux Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Bhatia  | Director | 12-Mar-2004 | Current |
| Jogesh Bhatia | Director | 12-Mar-2004 | Current |
| Sant Bhatia | Director | 26-Aug-2008 | Current |
Financial Performance of Blulux Laboratories.
Blulux Laboratories Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 11.45% decrease. The company also saw a substantial fall in profitability, with a 38.53% decrease in profit. The company's net worth moved up by a moderate rise of 4.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Blulux Laboratories?
In 2020, Blulux Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.83 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 0.70 Cr
- State Bank Of Bikaner And Jaipur : 0.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Apr 2017 | Others | ₹4.00 M | Open |
| 25 May 2004 | State Bank Of Bikaner And Jaipur | ₹1.30 M | Open |
| 22 May 2004 | Others | ₹3.00 M | Open |
How Many Employees Work at Blulux Laboratories?
Blulux Laboratories has a workforce of 14 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Blulux Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blulux Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.